138 related articles for article (PubMed ID: 32048938)
1. Adherence to Oral Anticancer Medications After Implementation of an Ambulatory Adherence Program at a Large Urban Academic Hospital.
Curry MA; Chineke I; Redelico T; Terrell C; Bell W; Flood D; Mishra P; LaFollette J; Power S; Bernal-Mizrachi L
JCO Oncol Pract; 2020 Apr; 16(4):e350-e356. PubMed ID: 32048938
[TBL] [Abstract][Full Text] [Related]
2. Impact of oncology pharmacist-managed oral anticancer therapy in patients with chronic myelogenous leukemia.
Lam MS; Cheung N
J Oncol Pharm Pract; 2016 Dec; 22(6):741-748. PubMed ID: 26419691
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Provider Adherence to Recommended Monitoring Parameters for Oral Anticancer Medications.
Redelico TJ; Walton SM; LaFollette J; Adams Curry M; Bernal-Mizrachi L
J Oncol Pract; 2018 Jul; 14(7):e446-e450. PubMed ID: 29813011
[TBL] [Abstract][Full Text] [Related]
4. Enhancing patients' understanding of and adherence to oral anticancer medication: Results of a longitudinal pilot intervention.
Lin M; Hackenyos D; Savidge N; Weidner RA; Murphy-Banks R; Fleckner T; Parsons SK; Rodday AM
J Oncol Pharm Pract; 2021 Sep; 27(6):1409-1421. PubMed ID: 32996363
[TBL] [Abstract][Full Text] [Related]
5. Expanding pharmacy practice through the use of pharmacy technicians as process navigators to facilitate patient access of oral anticancer agents.
Lau G; Alwan L; Chi M; Lentz M; Hone K; Segal E
J Am Pharm Assoc (2003); 2019; 59(4):586-592. PubMed ID: 31036528
[TBL] [Abstract][Full Text] [Related]
6. The impacts of a pharmacist-managed outpatient clinic and chemotherapy-directed electronic order sets for monitoring oral chemotherapy.
Battis B; Clifford L; Huq M; Pejoro E; Mambourg S
J Oncol Pharm Pract; 2017 Dec; 23(8):582-590. PubMed ID: 27733666
[TBL] [Abstract][Full Text] [Related]
7. Physician-pharmacist collaboration for oral chemotherapy monitoring: Insights from an academic genitourinary oncology practice.
Holle LM; Puri S; Clement JM
J Oncol Pharm Pract; 2016 Jun; 22(3):511-6. PubMed ID: 25900102
[TBL] [Abstract][Full Text] [Related]
8. The effectiveness of therapeutic patient education on adherence to oral anti-cancer medicines in adult cancer patients in ambulatory care settings: a systematic review.
Arthurs G; Simpson J; Brown A; Kyaw O; Shyrier S; Concert CM
JBI Database System Rev Implement Rep; 2015 Jun; 13(5):244-92. PubMed ID: 26455611
[TBL] [Abstract][Full Text] [Related]
9. Improved Adherence Rates and Clinical Outcomes of an Integrated, Closed-Loop, Pharmacist-Led Oral Chemotherapy Management Program.
Muluneh B; Schneider M; Faso A; Amerine L; Daniels R; Crisp B; Valgus J; Savage S
J Oncol Pract; 2018 Jun; 14(6):e324-e334. PubMed ID: 29799768
[TBL] [Abstract][Full Text] [Related]
10. Assessment of patients' understanding of and adherence to oral anticancer medication (OAM): Results of a cross-sectional institutional pilot study.
Rodday AM; Hackenyos D; Masood R; Savidge N; Lin M; Weidner RA; Parsons SK
J Oncol Pharm Pract; 2021 Oct; 27(7):1569-1577. PubMed ID: 33019872
[TBL] [Abstract][Full Text] [Related]
11. Assessing the need for improved strategies and medication-related education to increase adherence for oral anticancer medications in the young adult oncology population.
Divakaruni A; Saylor E; Duffy AP
J Oncol Pharm Pract; 2018 Jul; 24(5):337-342. PubMed ID: 28387636
[TBL] [Abstract][Full Text] [Related]
12. A Novel Approach to Better Characterize Medication Adherence in Oral Anticancer Treatments.
Schneider MP; Achtari Jeanneret L; Chevaux B; Backes C; Wagner AD; Bugnon O; Luthi F; Locatelli I
Front Pharmacol; 2018; 9():1567. PubMed ID: 30761009
[No Abstract] [Full Text] [Related]
13. A pilot study to assess the pharmacy impact of implementing a chemotherapy-induced nausea or vomiting collaborative disease therapy management in the outpatient oncology clinics.
Jackson K; Letton C; Maldonado A; Bodiford A; Sion A; Hartwell R; Graham A; Bondarenka C; Uber L
J Oncol Pharm Pract; 2019 Jun; 25(4):847-854. PubMed ID: 29587608
[TBL] [Abstract][Full Text] [Related]
14. Pharmacist intervention to improve medication adherence in heart failure: a randomized trial.
Murray MD; Young J; Hoke S; Tu W; Weiner M; Morrow D; Stroupe KT; Wu J; Clark D; Smith F; Gradus-Pizlo I; Weinberger M; Brater DC
Ann Intern Med; 2007 May; 146(10):714-25. PubMed ID: 17502632
[TBL] [Abstract][Full Text] [Related]
15. Specialty pharmacy for hematologic malignancies.
Fajardo S; Zook F; Dotson E
Am J Health Syst Pharm; 2016 Jun; 73(11):797-809. PubMed ID: 27126835
[TBL] [Abstract][Full Text] [Related]
16. Why individual-level interventions are not enough: Systems-level determinants of oral anticancer medication adherence.
Dean LT; George M; Lee KT; Ashing K
Cancer; 2020 Aug; 126(16):3606-3612. PubMed ID: 32438466
[TBL] [Abstract][Full Text] [Related]
17. Impact of Pharmacist-Led Patient Education in an Ambulatory Cancer Center: A Pilot Quality Improvement Project.
Park D; Patel S; Yum K; Smith CB; Tsao CK; Kim S
J Pharm Pract; 2022 Apr; 35(2):268-273. PubMed ID: 33153388
[TBL] [Abstract][Full Text] [Related]
18. Trends in the delivery of care to oncology patients in the United States: Emphasis on the role pharmacists on the healthcare team.
Ignoffo RJ; Knapp KK; Seung A; Brown V; Hough S; Rieband G; Dang TO; Palumbo A; Urmanski A
J Oncol Pharm Pract; 2021 Jan; 27(1):5-13. PubMed ID: 32237957
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer oral anti-cancer medication adherence: a systematic review of psychosocial motivators and barriers.
Lin C; Clark R; Tu P; Bosworth HB; Zullig LL
Breast Cancer Res Treat; 2017 Sep; 165(2):247-260. PubMed ID: 28573448
[TBL] [Abstract][Full Text] [Related]
20. Design Considerations in the Development of App-Based Oral Anticancer Medication Management Systems: a Qualitative Evaluation of Pharmacists' and Patients' Perspectives.
Ali EE; Chan SSL; Poh HY; Susanto YA; Suganya T; Leow JL; Pang CK; Chew L; Yap KY
J Med Syst; 2019 Feb; 43(3):63. PubMed ID: 30726518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
